BI 3000202

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for BI 3000202, covering 2024-11-13 to 2026-06-08. Get the full timeline:

Most recent: Clinical Trial Results: A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood [Phase 1]

See pricing